Physician profile
Alan B Aker
NPI 1841269669
$8,268.27
in general payments reported to CMS, 2019-2025
14 companies · $380 in 2025
The $380 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $245 · 2020: $70.94 · 2021: $1,698 · 2022: $5,181 · 2023: $296 · 2024: $398 · 2025: $380.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,074.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,073.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $7,131.91 | 2019-2025 | Catalys System, Tecnis Iol, Tecnis Iol |
| Abbvie INC. | $354.06 | 2023-2025 | Lumigan, Alphagan P, Durysta |
| New World Medical,INC. | $159.98 | 2025 | Kahook Dual Blade, Ahmed Glaucoma Valve, Streamline |
| Allergan, INC. | $144.52 | 2019-2021 | |
| Alcon Vision LLC | $87.33 | 2024-2025 | Clareon, Unity, Ngenuity |
| Rxsight INC | $80.97 | 2024 | Light Adjustable Lens (Lal), Rxsight Injector Cartridge, Rxsight Injector Handpiece |
| Omeros Corporation | $63.07 | 2021 | |
| Bausch & Lomb Americas INC. | $48.27 | 2023 | Ic-8 Apthera Iol, Xiidra, Envista Mx60 Iol |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $46.60 | 2019-2020 | |
| Kala Pharmaceuticals, INC. | $45.73 | 2019-2020 | |
| Rayner Intraocular Lenses Limited | $36.45 | 2022-2024 | Rayone Spheric, Omidria, Rayone Aspheric |
| Sun Pharmaceutical Industries INC. | $34.47 | 2021 | |
| Mallinckrodt Hospital Products INC. | $18.83 | 2024 | Acthar |
| Novartis Pharmaceuticals Corporation | $16.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Aker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.